The best indicator for Globe Life (GL)
We backtested 20 indicators across daily, weekly and hourly charts on real Globe Life (GL) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Donchian Breakout
On the weekly chart, this is the strongest risk-adjusted edge we found for Globe Life (GL) over ~45.8 years — trailing buy-and-hold by 5.0% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Donchian Breakout ✓ | Weekly | 6.0% | 0.47 | -49.6% | 52.8% | 36 | -5.0% |
| 2 | EMA-10 Trend ✓ | Weekly | 7.1% | 0.46 | -58.0% | 52.8% | 216 | -3.9% |
| 3 | Heikin-Ashi Trend ✓ | Weekly | 6.8% | 0.44 | -46.7% | 50.5% | 434 | -4.2% |
| 4 | Donchian Midline ✓ | Weekly | 6.7% | 0.44 | -67.9% | 52.3% | 128 | -4.3% |
| 5 | Bollinger Breakout ✓ | Weekly | 4.9% | 0.43 | -39.5% | 50.0% | 44 | -6.1% |
| 6 | MACD ✓ | Weekly | 6.3% | 0.42 | -56.5% | 55.9% | 93 | -4.7% |
| 7 | Money Flow Index ✓ | Daily | 6.1% | 0.41 | -70.1% | 81.8% | 44 | -4.9% |
| 8 | EMA 20/50 Cross ✓ | Daily | 6.2% | 0.4 | -62.7% | 42.7% | 103 | -4.8% |
| 9 | Donchian Midline ✓ | Daily | 5.8% | 0.39 | -70.3% | 40.7% | 644 | -5.2% |
| 10 | RSI Mean-Reversion ✓ | Weekly | 5.0% | 0.39 | -61.9% | 86.7% | 15 | -6.1% |
| 11 | RSI Trend (>50) ✓ | Weekly | 5.3% | 0.37 | -57.9% | 42.1% | 133 | -5.7% |
| 12 | MACD ✓ | Daily | 5.1% | 0.35 | -64.3% | 46.3% | 469 | -5.9% |
| 13 | Donchian Breakout ✓ | Daily | 4.4% | 0.34 | -42.1% | 52.1% | 190 | -6.6% |
| 14 | WaveTrend (8/6/4) ✓ | Daily | 4.9% | 0.34 | -58.2% | 75.8% | 153 | -6.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Globe Life (GL), Donchian Breakout on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.